Ameriprise’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.55M Buy
23,658
+19,661
+492% +$1.29M ﹤0.01% 3060
2025
Q1
$282K Sell
3,997
-1,233
-24% -$87K ﹤0.01% 3664
2024
Q4
$344K Buy
5,230
+966
+23% +$63.5K ﹤0.01% 3643
2024
Q3
$301K Sell
4,264
-126
-3% -$8.9K ﹤0.01% 3629
2024
Q2
$291K Sell
4,390
-909
-17% -$60.3K ﹤0.01% 3592
2024
Q1
$360K Sell
5,299
-680
-11% -$46.2K ﹤0.01% 3533
2023
Q4
$369K Sell
5,979
-1,479
-20% -$91.4K ﹤0.01% 3557
2023
Q3
$440K Buy
7,458
+2,532
+51% +$149K ﹤0.01% 3452
2023
Q2
$294K Sell
4,926
-10,389
-68% -$620K ﹤0.01% 3609
2023
Q1
$895K Buy
15,315
+1,545
+11% +$90.3K ﹤0.01% 3207
2022
Q4
$783K Buy
13,770
+933
+7% +$53.1K ﹤0.01% 3233
2022
Q3
$726K Sell
12,837
-21
-0.2% -$1.19K ﹤0.01% 3252
2022
Q2
$824K Buy
12,858
+7,875
+158% +$505K ﹤0.01% 3196
2022
Q1
$323K Sell
4,983
-294
-6% -$19.1K ﹤0.01% 3616
2021
Q4
$351K Buy
5,277
+183
+4% +$12.2K ﹤0.01% 3622
2021
Q3
$311K Buy
5,094
+99
+2% +$6.04K ﹤0.01% 3551
2021
Q2
$309K Sell
4,995
-1,950
-28% -$121K ﹤0.01% 3627
2021
Q1
$411K Sell
6,945
-4,185
-38% -$248K ﹤0.01% 3474
2020
Q4
$664K Buy
11,130
+1,206
+12% +$71.9K ﹤0.01% 3239
2020
Q3
$541K Sell
9,924
-1,401
-12% -$76.4K ﹤0.01% 3210
2020
Q2
$581K Buy
11,325
+2,727
+32% +$140K ﹤0.01% 3147
2020
Q1
$386K Sell
8,598
-447
-5% -$20.1K ﹤0.01% 3218
2019
Q4
$483K Buy
9,045
+948
+12% +$50.6K ﹤0.01% 3343
2019
Q3
$377K Sell
8,097
-798
-9% -$37.2K ﹤0.01% 3381
2019
Q2
$448K Sell
8,895
-79,404
-90% -$4M ﹤0.01% 3360
2019
Q1
$4.53M Buy
88,299
+6,048
+7% +$310K ﹤0.01% 2294
2018
Q4
$3.86M Buy
82,251
+1,173
+1% +$55K ﹤0.01% 2297
2018
Q3
$4.55M Sell
81,078
-41,013
-34% -$2.3M ﹤0.01% 2398
2018
Q2
$6.16M Buy
122,091
+2,931
+2% +$148K ﹤0.01% 2095
2018
Q1
$5.83M Buy
119,160
+13,269
+13% +$650K ﹤0.01% 2060
2017
Q4
$5.45M Sell
105,891
-7,878
-7% -$405K ﹤0.01% 2064
2017
Q3
$5.94M Buy
113,769
+13,827
+14% +$721K ﹤0.01% 1969
2017
Q2
$5.1M Buy
99,942
+3,264
+3% +$167K ﹤0.01% 2063
2017
Q1
$4.87M Buy
96,678
+16,947
+21% +$853K ﹤0.01% 2071
2016
Q4
$3.76M Buy
79,731
+47,760
+149% +$2.25M ﹤0.01% 2275
2016
Q3
$1.59M Buy
31,971
+2,949
+10% +$147K ﹤0.01% 2681
2016
Q2
$1.4M Buy
29,022
+3,537
+14% +$171K ﹤0.01% 2711
2016
Q1
$1.15M Buy
25,485
+12,204
+92% +$552K ﹤0.01% 2777
2015
Q4
$716K Sell
13,281
-1,869
-12% -$101K ﹤0.01% 3094
2015
Q3
$747K Buy
15,150
+5,310
+54% +$262K ﹤0.01% 3076
2015
Q2
$573K Buy
9,840
+450
+5% +$26.2K ﹤0.01% 3336
2015
Q1
$540K Buy
9,390
+216
+2% +$12.4K ﹤0.01% 3174
2014
Q4
$463K Buy
9,174
+3,564
+64% +$180K ﹤0.01% 3151
2014
Q3
$262K Sell
5,610
-915
-14% -$42.7K ﹤0.01% 3291
2014
Q2
$294K Sell
6,525
-1,560
-19% -$70.3K ﹤0.01% 3168
2014
Q1
$341K Sell
8,085
-147
-2% -$6.2K ﹤0.01% 3069
2013
Q4
$324K Buy
8,232
+777
+10% +$30.6K ﹤0.01% 2988
2013
Q3
$267K Buy
7,455
+2,388
+47% +$85.5K ﹤0.01% 3065
2013
Q2
$168K Buy
+5,067
New +$168K ﹤0.01% 3163